India’s CRDMO sector is set for growth in the next 3-5 years, with Jefferies highlighting four stocks including Divi’s Labs, Sai Life are expected to gain 17-30%. Concerns persist regarding high valuations and earnings volatility for Laurus Labs, which received an ‘Underperform’ rating.